Permeability versus Cerebral Blood Volume Measurement in Brain Tumor Evaluation: Comparative Clinical Value and Advice to Authors

References

1. ↵
   Cha S, Yang L, Johnson G, et al. Comparison of microvascular permeability measurements, Ktrans, determined with conventional steady state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR 2005;27:xx–xx
2. ↵
   Current literature reviews. Science 2005;309:1790
3. ↵
   Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared to conventional contrast enhanced MRI: confounding effect of elevated relative cerebral blood volume of oligodendrogiomas. AJNR 2004;25:214–21

   Abstract/FREE Full Text
4. ↵
   Provenzale J, Wang G, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–16

   CrossRefPubMedWeb of Science
5. ↵
   Ostergaard L, Hochberg F, Rabinov J, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300–305

   PubMedWeb of Science